BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 12610053)

  • 1. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).
    Monnier L; Lapinski H; Colette C
    Diabetes Care; 2003 Mar; 26(3):881-5. PubMed ID: 12610053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA(1c) in subjects with Type 2 diabetes.
    Peter R; Dunseath G; Luzio SD; Chudleigh R; Choudhury SR; Owens DR
    Diabet Med; 2009 Oct; 26(10):974-80. PubMed ID: 19900228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring.
    Wang JS; Tu ST; Lee IT; Lin SD; Lin SY; Su SL; Lee WJ; Sheu WH
    Diabetes Metab Res Rev; 2011 Jan; 27(1):79-84. PubMed ID: 21218511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients: variations with levels of HbA1c.
    Kikuchi K; Nezu U; Shirakawa J; Sato K; Togashi Y; Kikuchi T; Aoki K; Ito Y; Kimura M; Terauchi Y
    Endocr J; 2010; 57(3):259-66. PubMed ID: 20086313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetes.
    Schernthaner G; Guerci B; Gallwitz B; Rose L; Nicolay C; Kraus P; Kazda C
    Diabetes Metab; 2010 Nov; 36(5):389-94. PubMed ID: 20598608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of fasting and postprandial hyperglycemia to hemoglobin A1c in insulin-treated Japanese diabetic patients.
    Shimizu H; Uehara Y; Okada S; Mori M
    Endocr J; 2008 Aug; 55(4):753-6. PubMed ID: 18497454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting prandial hyperglycemia: how important is it and how best to do this?
    Monnier L; Colette C
    Curr Diab Rep; 2008 Oct; 8(5):368-74. PubMed ID: 18778585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.
    Ozmen S; Cil T; Atay AE; Tuzcu AK; Bahceci M
    Diabet Med; 2006 Oct; 23(10):1151-4. PubMed ID: 16978383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative contributions of fasting and postprandial glucose increments, glycemic variability, and non-glycemic factors to HbA1c in individuals with type 1 diabetes.
    Zhou Y; Zheng M; Deng H; Zheng X; Luo S; Yang D; Mai X; Xu W; Yan J; Weng J
    J Diabetes; 2023 Jun; 15(6):465-473. PubMed ID: 37143431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased glycemic variability and decrease of the postprandial glucose contribution to HbA1c in obese subjects across the glycemic continuum from normal glycemia to first time diagnosed diabetes.
    Fysekidis M; Cosson E; Banu I; Duteil R; Cyrille C; Valensi P
    Metabolism; 2014 Dec; 63(12):1553-61. PubMed ID: 25308444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daytime variability of postprandial glucose tolerance and pancreatic B-cell function using 12-h profiles in persons with Type 2 diabetes.
    Peter R; Dunseath G; Luzio SD; Chudleigh R; Roy Choudhury S; Owens DR
    Diabet Med; 2010 Mar; 27(3):266-73. PubMed ID: 20536488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between diurnal glucose levels and HbA1c in type 2 diabetes.
    Pistrosch F; Koehler C; Wildbrett J; Hanefeld M
    Horm Metab Res; 2006 Jul; 38(7):455-9. PubMed ID: 16933182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes.
    Monnier L; Colette C; Rabasa-Lhoret R; Lapinski H; Caubel C; Avignon A; Boniface H
    Diabetes Care; 2002 Apr; 25(4):737-41. PubMed ID: 11919134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements.
    Dailey G
    Mayo Clin Proc; 2007 Feb; 82(2):229-35; quiz 236. PubMed ID: 17290732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L).
    Liberopoulos EN; Florentin M; Kei A; Mountzouri E; Agouridis A; Elisaf MS
    J Clin Hypertens (Greenwich); 2010 Jul; 12(7):543-8. PubMed ID: 20629819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
    Giugliano D; Ceriello A; Razzoli E; Esposito K
    Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control.
    Fonseca V; Grunberger G; Gupta S; Shen S; Foley JE
    Diabetes Care; 2003 Jun; 26(6):1685-90. PubMed ID: 12766094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The features of postprandial glucose state in type 2 diabetes mellitus].
    Zhou J; Jia WP; Yu M; Ma XJ; Bao YQ; Lu W
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):970-5. PubMed ID: 16759538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.